Meeting
2018 ASCO Annual Meeting
Landscape of kinase rearrangements (kRE) detected in circulating tumor DNA (ctDNA).
Authors
Ben C. Creelan
H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Ben C. Creelan , Daniel S Lieber , Alexa Betzig Schrock , Russell Madison , Jeffrey S. Ross , Jared White , Vincent A. Miller , Samuel Jacob Klempner , Sumanta K. Pal , Sai-Hong Ignatius Ou , Doron Lipson , Jon Chung , Allison W. Welsh , Siraj Mahamed Ali
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 36, 2018 (suppl; abstr 12041)
DOI
10.1200/JCO.2018.36.15_suppl.12041
Abstract #
12041
Poster Bd #
154
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Expanding the use of targeted therapy for urothelial bladder cancer (UBC): Non-FGFR3 receptor tyrosine kinase (RTK) gene rearrangements (ReAr) and fusions (fus).
First Author: Andrea Necchi
Poster
2019 ASCO Annual Meeting
Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA), tumor mutational burden (TMB), and genomic loss of heterozygosity (gLOH).
First Author: Milind M. Javle
Poster
2020 ASCO Virtual Scientific Program
Pan-tumor analyses of kinase fusions detected in circulating tumor DNA (ctDNA) and concordance with paired tissue.
First Author: Jessica Kim Lee
Poster
2024 ASCO Annual Meeting
Characterization of diverse targetable ERBB2 alterations in 512,993 patients with solid tumors.
First Author: Dazhi Liu